Biological ActivitySBHA is a histone deacetylase (HDAC) inhibitor (ID50 values are 0.25 and 0.3 μM for HDAC1 and HDAC3 respectively). Potentiates the cytostatic effects of 5-Fluorouracil (Cat. No. 3257) in colorectal cancer cells.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells.
Zhang XD, Gillespie SK, Borrow JM, Hersey P.
Mol Cancer Ther.
Histone hyperacetylation induced by histone deacetylase inhibitors is not sufficient to cause growth inhibition in human dermal fibroblasts.
Brinkmann et al.
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.
Richon et al.
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for SBHA
There are currently no reviews for this product. Be the first to review SBHA and earn rewards!
Have you used SBHA?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image